ADENOSINE DEAMINASE, ADA-SYNOVIAL FLUID

Adenosine Deaminase (ADA) – Synovial Fluid is a specialized biochemistry test that measures adenosine deaminase enzyme activity in fluid collected from a joint. This joint fluid is known as synovial fluid.

ADA is an enzyme involved in purine metabolism and is associated with lymphocyte activity during cellular immune responses. Increased ADA activity in synovial fluid may support the evaluation of tuberculous arthritis, a form of tuberculosis affecting a joint.

Benefits of the Test

• Measures ADA enzyme activity in synovial fluid.
• Supports evaluation of suspected tuberculous arthritis.
• Provides additional information in patients with chronic joint swelling.
• May help differentiate tuberculous arthritis from selected non-tuberculous joint disorders.
• Supports clinical decisions while microbiological investigations are pending.
• Can be interpreted with synovial-fluid cell count and biochemical findings.
• Helps identify patients requiring additional tuberculosis investigations.
• Provides quantitative laboratory-based information.
• Supports orthopaedic, rheumatology, and infectious-disease evaluation.
• May contribute to earlier investigation of persistent joint inflammation.

Why Doctors Recommend This Test

Doctors may recommend this test when a patient has persistent swelling, pain, stiffness, reduced movement, or fluid accumulation in a joint and tuberculous arthritis is suspected. It may also be advised when routine synovial-fluid investigations are inconclusive or the patient has tuberculosis exposure, fever, night sweats, or unexplained weight loss.

Preparation Before Test

• This test requires synovial fluid rather than a routine blood sample.
• Synovial fluid is collected by a trained healthcare professional through joint aspiration or arthrocentesis.
• No fasting is generally required for the ADA analysis itself.
• Follow the doctor’s instructions before the joint-aspiration procedure.
• Inform the doctor about anticoagulants, aspirin, antiplatelet medicines, and all other medications.
• Do not stop prescribed medication unless specifically instructed by your doctor.
• Inform the doctor about bleeding disorders, allergies, recent joint injections, surgery, or injury.
• Tell the doctor if antibiotics or anti-tuberculosis medicines have already been started.
• The fluid must be collected in an appropriate sterile, leak-proof container.
• The specimen must be correctly labelled, processed, stored, and transported according to laboratory requirements.

Normal Reporting Time

The ADA Synovial Fluid test requires specialized biochemical analysis, result validation, and laboratory quality review. Results are generally available within a few working days after receipt of a suitable specimen. The exact reporting time may vary depending on the testing schedule, sample transportation, storage conditions, repeat analysis, and laboratory workflow.

Who Should Take This Test?

This test may be recommended for:

• Patients with suspected tuberculous arthritis.
• Individuals with persistent swelling of a single joint.
• Patients with chronic joint pain and restricted movement.
• People with unexplained synovial-fluid accumulation.
• Individuals with tuberculosis exposure and new joint symptoms.
• Patients with imaging findings suggestive of chronic joint infection.
• People with inconclusive routine synovial-fluid investigations.
• Immunocompromised individuals with suspected joint tuberculosis.
• Patients requiring differentiation of infectious and inflammatory arthritis.
• Individuals specifically advised to undergo testing by an orthopaedic specialist, rheumatologist, or physician.

Detailed Information

Synovial fluid is a lubricating fluid found inside movable joints such as the knee, hip, shoulder, ankle, elbow, and wrist. It reduces friction between joint surfaces and supports smooth movement.

Joint-fluid accumulation can occur due to bacterial infection, tuberculosis, inflammatory arthritis, crystal-related arthritis, injury, bleeding, or degenerative joint disease. Laboratory analysis helps doctors investigate the cause.

Tuberculous arthritis develops when Mycobacterium tuberculosis affects a joint. It commonly produces slowly progressive pain, swelling, stiffness, and reduced movement. Fever and other general tuberculosis symptoms may be mild or absent.

Large weight-bearing joints such as the hip and knee are frequently affected, although tuberculosis can involve other joints. Delayed diagnosis may lead to cartilage damage, bone destruction, deformity, or loss of joint function.

ADA converts adenosine into inosine as part of purine metabolism. Its activity is associated with lymphocytes, particularly T lymphocytes involved in immune responses against tuberculosis. Increased cellular immune activity within an infected joint may raise synovial-fluid ADA.

An elevated synovial-fluid ADA result may increase clinical suspicion of tuberculous arthritis when symptoms, imaging, exposure history, and other fluid findings support the diagnosis. However, diagnostic cut-off values may vary according to the laboratory method and patient population.

An elevated ADA result does not independently confirm joint tuberculosis. Increased values may also occur in bacterial septic arthritis, rheumatoid arthritis, crystal-related arthritis, and other inflammatory joint disorders.

A normal or low ADA result does not completely exclude tuberculous arthritis. Disease stage, previous treatment, immune status, specimen condition, and analytical sensitivity may affect the measured activity.

Additional synovial-fluid investigations may include appearance, viscosity, cell count and differential count, crystals, glucose, protein, Gram stain, bacterial culture, acid-fast bacillus smear, mycobacterial culture, and TB molecular testing.

Mycobacterial culture, molecular detection, or synovial biopsy with histopathological examination may provide more direct evidence of tuberculosis. X-ray, ultrasound, CT, or MRI may also be recommended depending on the affected joint.

Synovial fluid is collected through arthrocentesis. During this procedure, a trained healthcare professional cleans the skin and introduces a sterile needle into the joint to withdraw fluid. Ultrasound guidance may be used for deeper or difficult-to-access joints.

Blood contamination, insufficient volume, incorrect container use, delayed processing, or improper storage may affect specimen suitability and result reliability. The laboratory should receive accurate information about the joint and specimen source.

A hot, severely painful, rapidly swollen joint accompanied by fever or illness may indicate septic arthritis. This requires urgent medical evaluation and should not wait for routine test booking or an ADA result.

Results should always be interpreted with symptoms, examination findings, imaging, routine synovial-fluid analysis, microbiology, and histopathology when performed. Treatment should not be initiated or excluded solely on the basis of ADA.

At Focus Diagnostics, ADA Synovial Fluid testing is processed using established biochemical methodologies, appropriate specimen-handling procedures, analytical quality controls, and validation standards to provide clinically meaningful results.